The industry-leading NGS variant interpretation and reporting software now includes a new Clinical Validity feature, Dynamic Candidate Disease Identification, NICE…

Discover more about the latest QCI update and how the platform simplifies and accelerates NGS variant analysis, interpretation, and reporting…

How pharmaceutical companies can leverage real-world genomic data to overcome inefficiencies in cancer drug development In the June 2020 issue…

Next-generation sequencing (NGS) has transformed the field of oncology. Early successes in identifying and targeting oncogenic drivers of solid tumors…

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…

Introducing a novel myeloid gene panel for the GeneReader NGS System with integrated variant analysis, interpretation and reporting from QIAGEN…

We’re launching our new Sample to Insight QIAact Myeloid DNA UMI Panel! We are unveiling our new Sample to Insight…

As the number of genomes sequenced each day continues to skyrocket and healthcare professionals increasingly rely on genetic information to…

The recent AMP Europe 2018 conference was a wonderful chance to catch up with old friends and establish new relationships—our…

This week is the Advances in Genome Biology & Technology annual conference, taking place this year in Orlando. The QIAGEN…

Bioinformatic Tools for Genome Analysis The dust has settled after a whirlwind annual meeting of the American Society of Human…

Sample to Insight We’re just days away from heading to the annual meeting of the American Society of Human Genetics…